|
PrimidoneDrug - Primidone The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Primidone
Strength -
250MG
Applicant -
LANNETT
New Drug Application (NDA) Number -
084903
Product Number -
001
Therapeutic Equivalence (TE) Code -
AB
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Lannett Co Inc
Primidone
Mysoline 250mg/5ml Suspension; Oral
Mysoline 250mg Tablet; Oral Mysoline 50mg Tablet; Oral Primidone 250mg Tablet; Oral Citanest 1% Injectable; Injection Citanest 2% Injectable; Injection Citanest 3% Injectable; Injection Citanest Plain 4% Injectable; Injection Citanest Plain 4% Injectable; Injection Primaquine Eq 15mg Base Tablet; Oral NewDrugInformation |